It has also been reported that RNF126 can directly bind and regulate PTEN stability through polyubiquitination, making RNF126 an attractive target for augmenting cisplatin-based chemotherapy and regulating bladder cancer tumorigenesis. This evidence concerns the gene RNF126 and urinary bladder carcinoma.